Emergency Evidence Updates – February 2024
What’s new in the Critical Care literature – monthly updates
Continue reading »Year: 2024
ARiE Trial – Rifaximin for encephalopathy
In critically ill adults with overt acute hepatic encephalopathy (HE) admitted to ICU, does the addition of rifaximin to broad spectrum antimicrobials affect time to resolution of HE?
Continue reading »Critical Care Evidence Updates – January 2024
What’s new in the Critical Care literature – monthly updates
Continue reading »Emergency Evidence Updates – January 2024
What’s new in the Critical Care literature – monthly updates
Continue reading »PROPHY-VAP: Ceftriaxone to prevent early ventilator-associated pneumonia
In patients with severe brain injury who require mechanical ventilation, does an early, single dose of ceftriaxone compared with placebo reduce the incidence of early VAP?
Continue reading »Critical Care Evidence Updates – December 2023
What’s new in the Critical Care literature – monthly updates
Continue reading »Emergency Evidence Updates – December 2023
What’s new in the Critical Care literature – monthly updates
Continue reading »EARLYDRAIN – Lumbar Cerebrospinal Fluid Drain Among Patients With aSAH
In patients with aneurysmal subarachnoid haemorrhage (aSAH), does lumbar CSF drainage compared to standard therapy improve clinical outcomes as measured by the modified Rankin Scale (mRS) score at 6 months?
Continue reading »ACORN
In acutely ill adults (ED / ICU) does the administration of cefipime or piperacillin-tazobactam (pip-taz) result in an increased incidence of AKI or death by day 14?
Continue reading »Critical Care Evidence Updates – November 2023
What’s new in the Critical Care literature – monthly updates
Continue reading »